Phoundry Pharmaceuticals, Intarcia deal

By WIR Staff | Sep 28, 2015 | 7:00 AM GMT

Intarcia acquired Phoundry for an undisclosed sum. The deal gives Intarcia a portfolio of optimized peptides, which the

Read the full 180 word article

How to gain access

Continue reading with a
two-week free trial.